Powered by

-Assertio Therapeutics Agrees to Merge with Zyla Life Sciences to Create Synergistic Portfolio of Neurology and Non-Opioid Pain Products

Mar 17, 2020 - ENP Newswire
Board and Executive Moves-Mergers and Acquisitions

LAKE FOREST - Assertio Therapeutics, Inc. ('Assertio' or 'the Company') (NASDAQ: ASRT) and Zyla Life Sciences ('Zyla') (OTCQX: ZCOR), today announced that they have entered into a definitive merger agreement (the 'Agreement').

Under the terms of the Agreement, upon the effective time of the merger (the 'Merger'), Zyla stockholders will be entitled to receive 2.5 shares of common stock of a newly-formed holding company for each share of Zyla common stock held and the newly combined c...